14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $40.39 $44.07 Friday, 3rd May 2024 IONS stock ended at $41.97. This is 2.60% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $41.93 to a day high of $43.76.
90 days $40.39 $51.98
52 weeks $34.79 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Sep 28, 2023 $46.87 $47.20 $46.03 $46.26 1 713 960
Sep 27, 2023 $46.74 $47.72 $45.99 $47.13 2 083 419
Sep 26, 2023 $43.94 $46.54 $43.55 $46.28 2 627 117
Sep 25, 2023 $42.66 $43.05 $41.94 $42.66 714 414
Sep 22, 2023 $42.65 $43.07 $42.15 $42.71 639 007
Sep 21, 2023 $42.18 $42.63 $41.57 $42.48 527 367
Sep 20, 2023 $42.90 $43.32 $42.35 $42.54 1 051 695
Sep 19, 2023 $42.96 $43.46 $42.72 $42.98 633 050
Sep 18, 2023 $43.05 $43.08 $42.32 $42.93 885 093
Sep 15, 2023 $43.39 $43.51 $42.45 $42.91 1 250 789
Sep 14, 2023 $43.55 $44.51 $43.33 $43.64 1 373 908
Sep 13, 2023 $43.51 $43.67 $42.36 $43.15 977 324
Sep 12, 2023 $41.51 $43.65 $41.26 $43.51 1 250 309
Sep 11, 2023 $41.11 $41.77 $40.40 $41.29 759 384
Sep 08, 2023 $40.64 $41.96 $40.55 $41.21 997 953
Sep 07, 2023 $39.70 $40.52 $39.62 $40.38 553 796
Sep 06, 2023 $39.48 $39.91 $39.08 $39.79 661 708
Sep 05, 2023 $40.42 $40.42 $39.29 $39.34 826 724
Sep 01, 2023 $40.50 $40.98 $40.39 $40.50 441 746
Aug 31, 2023 $40.63 $40.74 $40.18 $40.27 665 913
Aug 30, 2023 $41.14 $41.51 $40.36 $40.57 587 763
Aug 29, 2023 $40.86 $41.50 $40.45 $41.06 483 509
Aug 28, 2023 $40.38 $40.86 $40.34 $40.86 457 118
Aug 25, 2023 $39.81 $40.48 $39.39 $40.32 462 484
Aug 24, 2023 $39.69 $40.13 $39.15 $39.81 486 865
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT